ST. HELIER, Jersey (AP) _ NovoCure Ltd. (NVCR) on Thursday reported a loss of $4.6 million in its first quarter.

On a per-share basis, the St. Helier, Jersey-based company said it had a loss of 4 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The oncology drug developer posted revenue of $137.5 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $135.9 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News